More questions over label changes

Pharmacy groups have welcomed proposals to alter the advisory labels of a number of medicines, although questions have been raised over new indications for lidocaine The proposals are part of a series of advisory label changes by the Therapeutic Goods Administration (TGA) for Required Advisory Statements for Medicine Labels, and included a number of different

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The next phase
Next The top ten